Mirum Pharmaceuticals Inc (MIRM)

$42.28 -$1.75 (-4.01%) 4:38 PM 12/12/24
NASDAQ | $USD | Biotechnology

Stock Data

  • Market Cap

    $2.14B
  • Day's Range

    $41.82 - $43.97
  • Volume

    357,958
  • 52 Week Low / High

    $23.14 - $48.89
  • PE Ratio

    -
  • PEG Ratio

    -
  • Dividend Frequency

    -

MIRM's Dividend
-
Amount
-
Dividend Yield
-
Payment Date
-
Annual Dividend Amount
Dividend Streak
Hypothetical 10k Investment Jan 1, 2020
Capital Growth
Dividend Return to Date
Dividend Payout year Est.
Expenses
Total Return
Total Return %
Analyists Ranking
7
Strong Buy
4
Buy
0
Hold
0
Sell
0
Strong Sell
$55.43
Target Price

Company News

  • Mirum (MIRM) Banks on Livmarli Sales Despite Recent Setback — Jan 23rd, 2024

    Mirum Pharmaceuticals, Inc. MIRM develops novel therapies for treating rare liver diseases affecting children and adults. The company’s lead product, Livmarli (maralixibat), an orally administered ileal bile acid transporter (“IBAT”) inhibitor, is approved for the treatment of choles...

Similar Stocks

  • AKRO.US Logo

    AKRO

    Akero Therapeutics Inc

  • KROS.US Logo

    KROS

    Keros Therapeutics inc

  • NAMS.US Logo

    NAMS

    Newamsterdam Pharma Company N.v. Ordinary Shares

  • SLNO.US Logo

    SLNO

    Soleno Therapeutics Inc

Want to be notified on dividend changes?

Start manging your portfolio today.

Sign up for free